MDT vs. ABT, ISRG, SYK, BSX, BDX, IDXX, EW, RMD, DXCM, and STE
Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.
Medtronic received 654 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 75.81% of users gave Medtronic an outperform vote while only 69.74% of users gave Abbott Laboratories an outperform vote.
Abbott Laboratories presently has a consensus target price of $125.15, suggesting a potential upside of 9.18%. Medtronic has a consensus target price of $94.64, suggesting a potential upside of 7.38%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, equities analysts clearly believe Abbott Laboratories is more favorable than Medtronic.
Abbott Laboratories has a net margin of 13.65% compared to Medtronic's net margin of 12.06%. Abbott Laboratories' return on equity of 20.18% beat Medtronic's return on equity.
In the previous week, Abbott Laboratories had 11 more articles in the media than Medtronic. MarketBeat recorded 29 mentions for Abbott Laboratories and 18 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 0.82 beat Medtronic's score of 0.48 indicating that Abbott Laboratories is being referred to more favorably in the media.
Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.
Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 1.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.2%. Abbott Laboratories pays out 68.5% of its earnings in the form of a dividend. Medtronic pays out 101.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 53 consecutive years and Medtronic has raised its dividend for 48 consecutive years.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Abbott Laboratories beats Medtronic on 16 of the 22 factors compared between the two stocks.
Get Medtronic News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medtronic Competitors List
Related Companies and Tools
This page (NYSE:MDT) was last updated on 10/8/2024 by MarketBeat.com Staff
